Immunocompromised individuals face ongoing COVID-19 risks despite vaccination, highlighting the need for tailored public health strategies and innovative therapies.
Chandler H. Park, MD, MS, FACP
Advertisement
Articles by Chandler H. Park, MD, MS, FACP
Explore the latest advancements in sarcoma immunotherapy, focusing on tumor microenvironment modulation and innovative treatment strategies for improved patient outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
Nogapendekin Alfa/BCG BLA Resubmitted for NMIBC Population
3
Considering Venlafaxine as Distress Treatment in Breast Cancer
4
Can Anti-Inflammatory Pathway-Targeting Treatment Work in Early Onset CRC?
5